Comparative Analysis of Two HER2 Immunohistochemistry Scoring Methods in Breast Carcinoma: Implications for HER2-Low Classification
Background: Breast cancer is one of the most common carcinomas worldwide and remains the leading cause of cancer-related death among women. A key biomarker used to guide treatment decisions in breast carcinoma is the expression of human epidermal growth factor receptor 2 (HER2). However, the assessment of HER2 expressi...